Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00741091 · ClinicalTrials.gov registry record · Phase 4
A Carotid Stenting Boston Scientific Surveillance Program
A Phase 4 study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,097
- Enrollment target
NCT00741091: Completed Phase 4 study, sponsored by Boston Scientific Corporation.
NCT00741091 is a Phase 4 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,097 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (112% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00741091, a Phase 4 study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,097 participants
- Enrollment target
Study Summary
CABANA is a multicenter U.S. surveillance registry that will be conducted to compile early clinical outcomes data for the Carotid WALLSTENT Endoprosthesis and FilterWire EZ System in routine clinical practice and to assess the adequacy of the Boston Scientific Corporation (BSC) Carotid Stenting Training Program.
Primary Outcome
Number of participants who experienced a major adverse event (MAE) 0-30 days post-procedure. MAE was defined as add death, stroke, and myocardial infarction(MI).
Interventions
- DEVICE Carotid WALLSTENT Monorail Endoprosthesis
- DEVICE FilterWire EZ™ System™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,097 participants |
| Start Date | 2008-12 |
| Est. Completion | 2010-10 |
| Phase | Phase 4 |
What the finished NCT00741091 record still lists
NCT00741091 is an interventional study that assigns participants to a tested intervention. Its 1,097 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (112% higher).
The record links to 0 conditions, and to 2 interventions - of which Carotid WALLSTENT Monorail Endoprosthesis is the first listed.
NCT00741091 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00741091 about?
NCT00741091 is a clinical study titled "A Carotid Stenting Boston Scientific Surveillance Program". CABANA is a multicenter U.S. surveillance registry that will be conducted to compile early clinical outcomes data for the Carotid WALLSTENT Endoprosthesis and FilterWire EZ System in routine clinical practice and to assess the adequacy of the Boston Scientific Corporation (BSC) Carotid Stenting Trai...
What is the current status of trial NCT00741091?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,097 participants. The study started on 2008-12. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00741091?
The interventions under investigation include: Carotid WALLSTENT Monorail Endoprosthesis (DEVICE), FilterWire EZ™ System™ (DEVICE).
Who is sponsoring clinical trial NCT00741091?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00741091's enrollment target sits among peer trials
1,097 65th of 2000 higher than 1,936 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06191744 · 1,095 participants · Phase 3
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT04743765 · 1,100 participants · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia